Searched for
BIOASIA 2019
Healthcare experts urge India to rewrite clinical trial rules to boost global market shareHealthcare experts suggest that India could increase its share in the global clinical trials market by learning from countries like China a...- Indian pharmaceutical firms go local for APIs, seeking to end reliance on ChinaThough India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounte...
- 82% healthcare startups are offering improved affordability in their products: EY surveyThe report highlights how technology is disrupting the health care ecosystem in India as we are entering the Fourth Industrial Revolution.
- Healthcare Startups have finger on the pulseThe report, released at the three-day BioAsia 2019 conference in Hyderabad on Monday, said that as many as 71% startups that participated i...
- Telangana teams up with Cerestra to set up India’s first life sciences infra fundRao said the first of its kind fund will create sophisticated modular plug-and-play specialised infrastructure for pharmaceuticals, biotech...
- Biologics worth $50 bn to lose patent protection in USA:Report"It is estimated that between 2009 and 2019, 21 biologics with a market value of over $ 50 billion will lose patent protection in the US al...
- Govt sees merchandise exports falling for few more monthsIndia's merchandise exports, which have been declining for several months in row, will continue to fall for some more months thanks to seri...
Load More